Similar Papers

Paper Title
Journal
Date
Author
Conditioning for Allogeneic Marrow Transplantation in Patients With Lymphohematopoietic Malignancies Without the Use of Total Body Irradiation
Ea Copelan ... Hj Deeg
Blood | VOL. 80
Ea Copelan, et. al.Ea Copelan ... Hj Deeg
01 Oct 1992
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens
Ra Clift ... P Beatty
Blood | VOL. 77
Ra Clift, et. al.Ra Clift ... P Beatty
15 Apr 1991
Allogeneic Marrow Transplantation in Patients With Chronic Myeloid Leukemia in the Chronic Phase: A Randomized Trial of Two Irradiation Regimens
Ra Clift ... Ld Fisher
Blood | VOL. 77
Ra Clift, et. al.Ra Clift ... Ld Fisher
15 Apr 1991
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens [see comments
Ra Clift ... Ld Fisher
Blood | VOL. 76
Ra Clift, et. al.Ra Clift ... Ld Fisher
01 Nov 1990
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Brentuximab vedotin and nivolumab for cHL.
-
Blood | VOL. 145
--
16 Jan 2025
B-1 B cells lose self-control in SCD.
David R Gibb ... Sean R Stowell
Blood | VOL. 145
David R Gibb, et. al.David R Gibb ... Sean R Stowell
16 Jan 2025
Is it time to screen for multiple myeloma?
Irene M Ghobrial ... Floris Chabrun
Blood | VOL. 145
Irene M Ghobrial, et. al.Irene M Ghobrial ... Floris Chabrun
16 Jan 2025
Daratumumab for maintenance in myeloma.
Cyrille Touzeau ... Aurore Perrot
Blood | VOL. 145
Cyrille Touzeau, et. al.Cyrille Touzeau ... Aurore Perrot
16 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.